FDA Approves 2nd Gene Therapy

THURSDAY, Oct. 19, 2017 (HealthDay News) — The U.S. Food and Drug Administration has approved the second gene therapy for use in the United States. The new treatment, Yescarta (axicabtagene ciloleucel), is for a kind of blood cancer called large B-cell lymphoma. The treatment is known as chimeric antigen receptor (CAR) T cell therapy, and…

Does Your Dog ‘Talk’ to You?

THURSDAY, Oct. 19, 2017 (HealthDay News) — Some people swear their dogs can communicate with them. A new study adds some credence to that belief. Dogs use more facial expressions when people are looking at them — likely in an attempt to communicate with humans, researchers in the United Kingdom concluded. “The findings appear to…

Gung Ho for Green Tea

THURSDAY, Oct. 19, 2017 (HealthDay News) — Whether to relax, warm up or even curb your appetite, there’s nothing quite like sipping a soothing cup of tea. And while there’s no shortage of brews available, green tea in particular has many potential advantages. There are actually three types of tea leaves: green tea, black tea…

The Upsides and Downsides of Telecommuting

WEDNESDAY, Oct. 18, 2017 (HealthDay News) — Workers who “telecommute” appear to have a lot more job satisfaction than folks who report to an office every day. But that positive comes with tradeoffs. Remote employees may also have a harder time separating work from their personal lives, and they can become socially isolated, researchers report.…